Ninepoint Partners’s Merck MRK Stock Holding History

Ninepoint Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,327	Closed	-$659K	–	101
2024 Q2	$659K	Sell	5,327 -399	-7%	-$51.4K	0.06%	77
2024 Q1	$756K	Buy	+5,726	New	+$706K	0.08%	66
2023 Q3	–	Sell	-5,748	Closed	-$663K	–	98
2023 Q2	$663K	Hold	5,748	–	–	0.07%	53
2023 Q1	$612K	Buy	+5,748	New	+$621K	0.07%	55
2020 Q1	–	Sell	-5,402	Closed	-$469K	–	75
2019 Q4	$469K	Buy	+5,402	New	+$444K	0.15%	52
2019 Q3	–	Sell	-6,346	Closed	-$508K	–	104
2019 Q2	$508K	Buy	+6,346	New	+$486K	0.09%	62

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ninepoint Partners's MRK Position: Q3 2024 in Review

Ninepoint Partners sold out of Merck (MRK) in Q3 2024, closing a stake of 5,327 shares — an estimated $659K sold.

Ninepoint Partners first reported a position in MRK in Q2 2019 and held it in 6 quarters. The position peaked at $756K in Q1 2024. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

Ninepoint Partners reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
Ninepoint Partners sold 5,327 Merck shares in Q3 2024, an estimated $659K.
Ninepoint Partners first reported a position in Merck in Q2 2019 and held it in 6 quarters.
Ninepoint Partners's Merck position peaked at $756K in Q1 2024.
3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Ninepoint Partners's 13F filing for Q3 2024, filed 7 Nov 2024.